{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T06:46:56Z","timestamp":1784616416446,"version":"3.55.0"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,12,7]],"date-time":"2019-12-07T00:00:00Z","timestamp":1575676800000},"content-version":"vor","delay-in-days":401,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001807","name":"FAPESP","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Institute of Science and Translational Medicine","award":["465458\/2014-9"],"award-info":[{"award-number":["465458\/2014-9"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.bbi.2018.09.014","type":"journal-article","created":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T16:09:04Z","timestamp":1536682144000},"page":"241-251","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":77,"special_numbering":"C","title":["Cannabidiol prevents haloperidol-induced vacuos chewing movements and inflammatory changes in mice via PPAR\u03b3 receptors"],"prefix":"10.1016","volume":"74","author":[{"given":"Andreza B.","family":"Sonego","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas S.","family":"Prado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel T.","family":"Vale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia E.","family":"Sepulveda-Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thiago M.","family":"Cunha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos R.","family":"Tirapelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine A.","family":"Del Bel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Raisman-Vozari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco S.","family":"Guimar\u00e3es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2018.09.014_b0005","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s11940-011-0117-x","article-title":"Tardive dyskinesia","volume":"13","author":"Aia","year":"2011","journal-title":"Curr. Treat. Options Neurol."},{"issue":"1\u20133","key":"10.1016\/j.bbi.2018.09.014_b0010","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.schres.2014.12.037","article-title":"Altered IL-2, IL-6 and IL-8 serum levels in schizophrenia patients with tardive dyskinesia","volume":"162","author":"An","year":"2015","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbi.2018.09.014_b0015","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/imm.12443","article-title":"Immune mechanisms linked to depression via oxidative stress and neuroprogression","volume":"144","author":"Bakunina","year":"2015","journal-title":"Immunology"},{"key":"10.1016\/j.bbi.2018.09.014_b0020","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/s12640-009-9095-0","article-title":"Effects of \u03c9-3 essential fatty acids (\u03c9-3 EFAs) on motor disorders and memory dysfunction typical neuroleptic-induced: behavioral and biochemical parameter","volume":"17","author":"Barcelos","year":"2010","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.bbi.2018.09.014_b0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2008\/864140","article-title":"Regulation of glial cell functions by PPAR\u03b3 natural and synthetic agonists","volume":"2008","author":"Bernardo","year":"2008","journal-title":"PPAR Res."},{"key":"10.1016\/j.bbi.2018.09.014_b0030","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1189\/jlb.0212100","article-title":"The immune theory of psychiatric diseases: a key role for activated microglia and circulating monocytes","volume":"92","author":"Beumer","year":"2012","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.bbi.2018.09.014_b0035","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ejphar.2008.06.033","article-title":"Activation of striatal inflammatory mediators and caspase-3 is central to haloperidol-induced orofacial dyskinesia","volume":"590","author":"Bishnoi","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbi.2018.09.014_b0040","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.pnpbp.2008.05.003","article-title":"Differential striatal levels of TNF-\u03b1, NF\u03baB p65 subunit and dopamine with chronic typical and atypical neuroleptic treatment: role in orofacial dyskinesia","volume":"32","author":"Bishnoi","year":"2008","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2018.09.014_b0045","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1744-9081-8-12","article-title":"Relevance of animal models to human tardive dyskinesia","volume":"8","author":"Blanchet","year":"2012","journal-title":"Behav. Brain Funct."},{"key":"10.1016\/j.bbi.2018.09.014_b0050","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.expneurol.2016.09.009","article-title":"Striatal cholinergic interneurons and D2 receptor-expressing GABAergic medium spiny neurons regulate tardive dyskinesia","volume":"286","author":"Bordia","year":"2016","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bbi.2018.09.014_b0055","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.pbb.2005.05.002","article-title":"Ebselen attenuates haloperidol-induced orofacial dyskinesia and oxidative stress in rat brain","volume":"81","author":"Burger","year":"2005","journal-title":"Pharmacol. Biochem. Behav"},{"key":"10.1016\/j.bbi.2018.09.014_b0060","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.phrs.2016.01.033","article-title":"Cannabidiol, neuroprotection and neuropsychiatric disorders","volume":"112","author":"Campos","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bbi.2018.09.014_b0065","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0361-9230(03)00020-0","article-title":"Antidyskinetic effects of risperidone on animal models of tardive dyskinesia in mice","volume":"60","author":"Carvalho","year":"2003","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.bbi.2018.09.014_b0070","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.pnpbp.2012.10.018","article-title":"Oxidative stress and tardive dyskinesia: pharmacogenetic evidence","volume":"46","author":"Cho","year":"2013","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2018.09.014_b0075","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1016\/j.euroneuro.2015.08.004","article-title":"Microglial activation in the rat brain following chronic antipsychotic treatment at clinically relevant doses","volume":"25","author":"Cotel","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.bbi.2018.09.014_b0080","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ejphar.2015.12.032","article-title":"Beneficial effects of lycopene against haloperidol induced orofacial dyskinesia in rats: possible neurotransmitters and neuroinflammation modulation","volume":"771","author":"Datta","year":"2016","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.bbi.2018.09.014_b0085","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s00213-011-2415-0","volume":"219","author":"Deiana","year":"2012","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbi.2018.09.014_b0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1742-2094-9-71","article-title":"Prenatal stress causes alterations in the morphology of microglia and the inflammatory response of the hippocampus of adult female mice","volume":"9","author":"Diz-Chaves","year":"2012","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.bbi.2018.09.014_b0095","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.nbd.2016.06.013","article-title":"Co-administration of cannabidiol and capsazepine reduces L-DOPA-induced dyskinesia in mice","volume":"94","author":"Dos-Santos-pereira","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbi.2018.09.014_b0100","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/syn.890180303","article-title":"Alterations in dopamine receptor and neuropeptide gene expression in striatonigral and striatopallidal neurons in rats with vacuos chewing movements induced by chronic treatment with haloperidol","volume":"18","author":"Egan","year":"1994","journal-title":"Synapse"},{"key":"10.1016\/j.bbi.2018.09.014_b0105","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/BF02806012","article-title":"Pharmacological and neurochemical differences between acute and tardive vacuos chewing movements induced by haloperidol","volume":"127","author":"Egan","year":"1996","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbi.2018.09.014_b0110","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1038\/sj.bjp.0707337","article-title":"Cannabidiol in vivo blunts \u03b2-amyloid induced neuroinflammation by suppressing IL-1\u03b2 and iNOS expression","volume":"151","author":"Esposito","year":"2007","journal-title":"Br. J. Pharmacol."},{"issue":"12","key":"10.1016\/j.bbi.2018.09.014_b0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028668","article-title":"Cannabidiol reduces A\u03b2-induced neuroinflammation and promotes hippocampal neurogenesis through PPAR\u03b3 involvement","volume":"6","author":"Esposito","year":"2011","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.bbi.2018.09.014_b0120","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1365-2125.2012.04341.x","article-title":"Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?","volume":"75","author":"Fern\u00e1ndez-Ruiz","year":"2012","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.bbi.2018.09.014_b0125","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.pnpbp.2013.06.005","article-title":"Cannabidiol attenuates catalepsy induced by distinct pharmacological mechanisms via 5-HT1A receptor activation in mice","volume":"46","author":"Gomes","year":"2013","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2018.09.014_b0130","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.schres.2015.01.015","article-title":"Decreased glial reactivity could be involved in the antipsychotic-like effect of cannabidiol","volume":"164","author":"Gomes","year":"2015","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbi.2018.09.014_b0135","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.pbb.2013.08.001","article-title":"Possible effect of peroxisome proliferator-activated receptor (PPAR)-\u03b1 and \u03b3 agonist against a rat model of oral dyskinesia","volume":"111","author":"Grover","year":"2013","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"14","key":"10.1016\/j.bbi.2018.09.014_b0140","doi-asserted-by":"crossref","first-page":"8268","DOI":"10.1073\/pnas.95.14.8268","article-title":"Cannabidiol and (-)delta9-tetrahydrocannabinol are neuroprotective antioxidants","volume":"95","author":"Hampson","year":"1998","journal-title":"PNAS"},{"key":"10.1016\/j.bbi.2018.09.014_b0145","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1471-4159.2003.02327.x","article-title":"Neuroprotective effect of cannabidiol, a non-psychoactive component of Cannabis sativa, on \u03b2-amyloid-induced toxicity in PC12 cells","volume":"89","author":"Iuvone","year":"2004","journal-title":"J. Neurochem."},{"issue":"10","key":"10.1016\/j.bbi.2018.09.014_b0150","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.tips.2009.07.006","article-title":"Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb","volume":"30","author":"Izzo","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bbi.2018.09.014_b0155","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/jnc.12190","article-title":"Neuroprotective effects of PPAR-\u03b3 agonist rosiglitazone in N171\u201382Q mouse model of Huntington\u2019s disease","volume":"125","author":"Jin","year":"2013","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbi.2018.09.014_b0160","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1111\/j.1476-5381.2011.01461.x","article-title":"Differential transcriptional profiles mediated by exposure to the cannabinoids cannabidiol and \u03949-tetrahydrocannabinol in BV-2-microglial cells","volume":"165","author":"Junkat","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbi.2018.09.014_b0165","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1074\/jbc.M109.069294","article-title":"Canabinoids \u03949-tetrahydrocannabinol and cannabidiol differentially inhibit the lipopolysaccharide-activated NF-\u03baB and interferon-\u03b2\/STAT proinflammatory pathways in BV-2 microglial cells","volume":"285","author":"Kozela","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbi.2018.09.014_b0170","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1111\/j.1476-5381.2011.01379.x","article-title":"Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis-like disease in C57BL\/6 mice","volume":"163","author":"Kozela","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbi.2018.09.014_b0175","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1196\/annals.1369.003","article-title":"Dopamine quinones activate microglia and induce a neurotoxic gene expression profile. Relationship to methamphetamine-induced nerve ending damage","volume":"1074","author":"Kuhn","year":"2006","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bbi.2018.09.014_b0180","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2012.15","article-title":"Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia","volume":"2","author":"Leweke","year":"2012","journal-title":"Transl. Psychiatry"},{"issue":"5","key":"10.1016\/j.bbi.2018.09.014_b0185","first-page":"1","article-title":"Microglial cells as a link between cannabinoids and the immune hypothesis of psychiatric disorders","volume":"7","author":"Lisboa","year":"2016","journal-title":"Front. Neurol."},{"key":"10.1016\/j.bbi.2018.09.014_b0190","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/cercor\/bht202","article-title":"CB1 and CB2 cannabinoid receptor antagonists prevent minocycline-induced neuroprotection following traumatic brain injury in mice","volume":"25","author":"Lopez-Rodriguez","year":"2015","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.bbi.2018.09.014_b0195","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/0006-3223(90)90490-S","article-title":"Increased indices of free radical activity in the cerebrospinal fuid of patients with tardive dyskinesia","volume":"28","author":"Lohr","year":"1990","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.bbi.2018.09.014_b0200","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2165\/00023210-200317010-00004","article-title":"Oxidative mechanisms and tardive dyskinesia","volume":"17","author":"Lohr","year":"2003","journal-title":"CNS Drugs"},{"issue":"24","key":"10.1016\/j.bbi.2018.09.014_b0205","doi-asserted-by":"crossref","first-page":"3966","DOI":"10.1016\/j.febslet.2009.10.036","article-title":"Correlation of mRNA and protein in complex biological samples","volume":"583","author":"Maier","year":"2009","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbi.2018.09.014_b0210","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0166-4328(03)00192-X","article-title":"Haloperidol versus risperidone on rat \u201cearly onset\u201d vacuos chewing","volume":"149","author":"Marchese","year":"2004","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbi.2018.09.014_b0215","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.nbd.2013.06.016","article-title":"Cannabidiol provides long-lasting protection against deleterious effects of inflammation in a viral model of multiple sclerosis: a role of A2A receptors","volume":"59","author":"Mecha","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbi.2018.09.014_b0220","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.pharmthera.2005.08.007","article-title":"Peroxisome proliferator-activated receptors and inflammation","volume":"110","author":"Moraes","year":"2006","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bbi.2018.09.014_b0225","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ejphar.2005.02.040","article-title":"Cannabidiol inhibits the hyperlocomotion induced by psychotomimetic drugs in mice","volume":"512","author":"Moreira","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbi.2018.09.014_b0230","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.neuroscience.2003.08.064","article-title":"Immunolocalization of peroxisome proliferator-activated receptors and retinoid X receptors in the adult rat CNS","volume":"123","author":"Moreno","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbi.2018.09.014_b0235","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1124\/mol.111.071290","article-title":"Cannabidiol and other cannabinoids reduce microglial activation in vitro and in vivo: relevance to Alzheimer\u2019s disease","volume":"79","author":"Moreno","year":"2011","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bbi.2018.09.014_b0240","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0014-2999(01)01385-1","article-title":"Possible involvement of prostaglandins in haloperidol-induced orofacial dyskinesia in rats","volume":"430","author":"Naidu","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbi.2018.09.014_b0245","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/S0028-3908(03)00101-1","article-title":"Quercetin, a bioflavonoid, attenuates haloperidol-induced orofacial dyskinesia","volume":"44","author":"Naidu","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbi.2018.09.014_b0250","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ejphar.2009.03.010","article-title":"Time-dependent vascular actions of cannabidiol in the rat aorta","volume":"612","author":"O\u2019Sullivan","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbi.2018.09.014_b0255","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s11010-016-2702-5","article-title":"Cannabidiol promotes browning in 3T3-L1 adipocytes","volume":"416","author":"Parray","year":"2016","journal-title":"Mol. Cell. Biochem."},{"issue":"343","key":"10.1016\/j.bbi.2018.09.014_b0260","first-page":"1","article-title":"Cannabidiol prevents motor and cognitive impairments induced by reserpine in rats","volume":"7","author":"Peres","year":"2016","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbi.2018.09.014_b0265","doi-asserted-by":"crossref","first-page":"3424","DOI":"10.1111\/ejn.12341","article-title":"Neuroprotection and reduction of glial reaction by cannabidiol treatment after sciatic nerve transection in neonatal rats","volume":"38","author":"Perez","year":"2013","journal-title":"Eur. J. Neurosci."},{"issue":"9","key":"10.1016\/j.bbi.2018.09.014_b0270","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1007\/s11064-016-1961-6","article-title":"Alteration of cytokine levels in the striatum of rats: possible participation in vacuos chewing movements induced by antipsychotics","volume":"41","author":"Peroza","year":"2016","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.bbi.2018.09.014_b0275","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0092-8674(00)81410-5","article-title":"A cold-inducible coactivator of nuclear receptors linked to adaptative thermogenesis","volume":"92","author":"Puigserver","year":"1998","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.bbi.2018.09.014_b0280","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1158\/1535-7163.MCT-12-0335","article-title":"COX-2 and PPAR-\u03b3 confer cannabidiol-induced apoptosis of human lung cancer cells","volume":"12","author":"Ramer","year":"2013","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bbi.2018.09.014_b0285","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nature09615","article-title":"The myeloid cells of the central nervous system parenchyma","volume":"468","author":"Ransohoff","year":"2010","journal-title":"Nature"},{"issue":"6662","key":"10.1016\/j.bbi.2018.09.014_b0290","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/34178","article-title":"The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrofage activation","volume":"391","author":"Ricote","year":"1998","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.bbi.2018.09.014_b0295","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1248\/bpb.34.774","article-title":"Evaluation of the cyclooxygenase inhibiting effects of six major cannabinoids isolated from Cannabis sativa","volume":"34","author":"Ruhaak","year":"2011","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.bbi.2018.09.014_b0300","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1742-2094-8-5","article-title":"Cannabidiol reduces lipopolysaccharide-induced vascular changes and inflammation in the mouse brain: an intravital microscopy study","volume":"8","author":"Ruiz-Valdepe\u00f1as","year":"2011","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.bbi.2018.09.014_b0305","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/j.1460-9568.2007.05717.x","article-title":"Cannabidiol reduced the striatal atrophy caused 3-nitropropionic acid in vivo by mechanisms independent of the activation of cannabinoid, vanilloid TRPV1 and adenosine A2A receptors","volume":"26","author":"Sagredo","year":"2007","journal-title":"Eur. J. Neurosci."},{"issue":"11","key":"10.1016\/j.bbi.2018.09.014_b0310","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1002\/glia.23032","article-title":"A simplified approach for efficient isolation of functional microglial cells: application for modeling neuroinflammatory responses in vitro","volume":"64","author":"Sepulveda-Diaz","year":"2016","journal-title":"Glia"},{"key":"10.1016\/j.bbi.2018.09.014_b0315","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.bbr.2016.04.042","article-title":"Cannabidiol attenuates haloperidol-induced catalepsy and c-Fos protein expression in the dorsolateral striatum via 5-HT1A receptors in mice","volume":"309","author":"Sonego","year":"2016","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbi.2018.09.014_b0320","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.bbi.2007.09.011","article-title":"Antiinflamatory and neuroprotective actions of COX2 inhibitors in the injured brain","volume":"22","author":"Strauss","year":"2008","journal-title":"Brain Behav. Immun."},{"issue":"2","key":"10.1016\/j.bbi.2018.09.014_b0325","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.resinv.2012.12.005","article-title":"Preventive effect of irbesartan on bleomycin-induced lung injury in mice","volume":"51","author":"Tanaka","year":"2013","journal-title":"Respir. Investig."},{"key":"10.1016\/j.bbi.2018.09.014_b0330","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s00702-009-0232-y","article-title":"Effect of alpha lipoic acid on the tardive dyskinesia and oxidative stress induced by haloperidol in rats","volume":"116","author":"Thaakur","year":"2009","journal-title":"J. Neural Transm."},{"issue":"7","key":"10.1016\/j.bbi.2018.09.014_b0335","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s40265-016-0568-1","article-title":"Drug-induced dyskinesia, part 2: treatment of tardive dyskinesia","volume":"76","author":"Vijayakumar","year":"2016","journal-title":"Drugs"},{"key":"10.1016\/j.bbi.2018.09.014_b0340","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/BF02244189","article-title":"Effects of cannabidiol in animal models predictive of antipsychotic activity","volume":"104","author":"Zuardi","year":"1991","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbi.2018.09.014_b0345","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1590\/S0100-879X2006000400001","article-title":"Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug","volume":"9","author":"Zuardi","year":"2006","journal-title":"Braz. J. Med. Biol. Res."}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159118305828?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159118305828?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:53:04Z","timestamp":1760169184000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159118305828"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":69,"alternative-id":["S0889159118305828"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2018.09.014","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cannabidiol prevents haloperidol-induced vacuos chewing movements and inflammatory changes in mice via PPAR\u03b3 receptors","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2018.09.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}